Germany plans to start offering COVID-19 booster shots to the elderly and at-risk from September 1, according to a draft document seen by AFP on Sunday, as concerns grow about the spread of the Delta variant.
Aug 1, 2021
0
29
The European medicines watchdog said Thursday it was reviewing German-based pharmaceutical SK Chemicals' coronavirus vaccine which uses nanotechnology to combat the virus, amid concern of a possible comeback later in the ...
Aug 18, 2022
0
17
A special WHO-sanctioned session at this year's European Congress on Clinical Microbiology & Infectious Diseases (ECCMID) will ask how many more warnings the world needs before it is too late to address the growing threat ...
Jul 9, 2021
0
2
The new Omicron subvariant, BA.2, is spreading across the United States and will soon take over as the major COVID variant, White House chief medical adviser Dr. Anthony Fauci said Tuesday.
Mar 24, 2022
0
66
Artificial intelligence (AI) can be used to give stroke patients a personalised and more accurate risk for suffering a recurrence, according to a new study presented today at the European Stroke Organisation (ESO) Conference.
Sep 1, 2021
0
56
In 2017, the majority (58 percent) of the almost 27,000 newly reported hepatitis B cases in the European Union and European Economic Area were classified as chronic infections. This follows a consistent upward trend in reported ...
Jun 21, 2019
0
0
France will gradually reopen its borders to countries outside the Schengen zone from July 1, the interior and foreign ministers said in a joint statement on Friday.
Jun 13, 2020
0
1
Argentina President Alberto Fernandez on Friday announced the South American country would begin producing the Russian Sputnik V COVID-19 vaccine following a virtual meeting with his counterpart Vladimir Putin.
Jun 4, 2021
0
1
A U.N.-backed organization announced Thursday that it has signed agreements with more than two dozen generic drug makers to produce versions of Merck's COVID-19 pill to supply 105 developing countries.
Jan 20, 2022
0
6
Canada's health authority said Monday it has approved Pfizer's anti-COVID pill, Paxlovid, for adults at high risk of progressing to serious disease.
Jan 17, 2022
0
10
